These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2812975)

  • 1. [Treatment of vaso-occlusive crisis of sickle-cell disease with pentoxifylline].
    Clerc M; Doh-Egueli D; Chapuis F; Durin A; Bertrand Y; Souillet G; Philippe N
    Pediatrie; 1989; 44(7):577-81. PubMed ID: 2812975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Improvement of blood viscosity in sickle-cell anaemia by pentoxifylline (author's transl)].
    Keller F; Leonhardt H
    Dtsch Med Wochenschr; 1980 Jun; 105(25):898-900. PubMed ID: 7408665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind randomised clinical trial of pentoxiphyllin in vaso-occlusive sickle cell crisis.
    Teuscher T; Von Der Ahe CW; Baillod P; Holzer B
    Trop Geogr Med; 1989 Oct; 41(4):320-5. PubMed ID: 2635446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of treatment during osteoarticular pain crises in drepanocytosis; based on the example of pentoxifylline].
    Pichard E; Duflo B; Coulibaly S; Mariko B; Monsempes JL; Traore HA; Diallo AD
    Bull Soc Pathol Exot Filiales; 1987; 80(5):834-40. PubMed ID: 3450443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan.
    Olabode JO; Shokunbi WA
    West Afr J Med; 2006; 25(4):284-8. PubMed ID: 17402517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the vasoocclusive crisis of sickle cell disease IV. Mechanism of action of pentoxifylline (Trental).
    Ambrus JL; Meky N; Stadler S; Sills RH; Gastpar H; Raposa T
    J Med; 1988; 19(2):67-88. PubMed ID: 3171402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemorheological treatment of painful sickle cell crises. Use of pentoxifylline.
    Poflee VW; Gupta OP; Jain AP; Jajoo UN
    J Assoc Physicians India; 1991 Aug; 39(8):608-9. PubMed ID: 1814876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating vaso-occlusive crisis and infection in sickle cell anemia.
    Shah Y; Kumar A
    J Fam Pract; 1981 Oct; 13(5):752, 757. PubMed ID: 7276882
    [No Abstract]   [Full Text] [Related]  

  • 10. Tramadol infusion for the pain management in sickle cell disease: a case report.
    Erhan E; Inal MT; Aydinok Y; Balkan C; Yegul I
    Paediatr Anaesth; 2007 Jan; 17(1):84-6. PubMed ID: 17184440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Emergencies in adults with sickle cell disease].
    Godeau B
    Bull Acad Natl Med; 2004; 188(3):507-15; discussion 515-7. PubMed ID: 15584659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of blood viscosity in sickle cell anemia by pentoxifylline. A case report.
    Keller F; Leonhardt H
    J Med; 1979; 10(6):429-33. PubMed ID: 299452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
    Raphael JL; Kamdar A; Beavers MB; Mahoney DH; Mueller BU
    Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study: an open clinical trial of pentoxiphylline in patients with painful sickle cell crises.
    Khosla AA; Chintu C
    East Afr Med J; 1984 Nov; 61(11):829-36. PubMed ID: 6399024
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute pancreatitis during sickle cell vaso-occlusive painful crisis.
    Ahmed S; Siddiqui AK; Siddiqui RK; Kimpo M; Russo L; Mattana J
    Am J Hematol; 2003 Jul; 73(3):190-3. PubMed ID: 12827657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet distribution width (PDW) is increased in vaso-occlusive crisis in sickle cell disease.
    Amin MA; Amin AP; Kulkarni HR
    Ann Hematol; 2004 Jun; 83(6):331-5. PubMed ID: 15052371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on vasoocclusive crisis of sickle cell disease. I. Effect of pentoxifylline.
    Ambrus JL; Ambrus CM; Gastpar H; Bannerman R; Bettigole R; Friedman S
    J Med; 1979; 10(6):445-56. PubMed ID: 299453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline (Trental) has no significant effect on laboratory parameters in sickle cell disease.
    Billett HH; Kaul DK; Connel MM; Fabry ME; Nagel RL
    Nouv Rev Fr Hematol (1978); 1989; 31(6):403-7. PubMed ID: 2694097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the management and prevention of vasoocclusive crisis in sickle cell disease.
    Ambrus JL; Ambrus CM; Bannerman R; Sills RH; Meky NN
    J Med; 1984; 15(5-6):385-407. PubMed ID: 6100377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report.
    Ahmed S; Siddiqui AK; Iqbal U; Sison CP; Shahid RK; Sheth M; Patel DV; Russo LA
    Eur J Haematol; 2004 Mar; 72(3):213-6. PubMed ID: 14962240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.